201 related articles for article (PubMed ID: 36094644)
1. Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli.
Isakova A; Artykov A; Vorontsova Y; Dolgikh D; Kirpichnikov M; Gasparian M; Yagolovich A
Mol Biotechnol; 2023 Apr; 65(4):581-589. PubMed ID: 36094644
[TBL] [Abstract][Full Text] [Related]
2. Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH-DR5-B with Dual VEGFR2 and DR5 Receptor Specificity.
Yagolovich AV; Artykov AA; Isakova AA; Vorontsova YV; Dolgikh DA; Kirpichnikov MP; Gasparian ME
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682540
[TBL] [Abstract][Full Text] [Related]
3. Expression of soluble moloney murine leukemia virus-reverse transcriptase in Escherichia coli BL21 star (DE3) using autoinduction system.
Handayani CV; Laksmi FA; Andriani A; Nuryana I; Mubarik NR; Agustriana E; Dewi KS; Purnawan A
Mol Biol Rep; 2024 May; 51(1):628. PubMed ID: 38717629
[TBL] [Abstract][Full Text] [Related]
4. High-level production of membrane proteins in E. coli BL21(DE3) by omitting the inducer IPTG.
Zhang Z; Kuipers G; Niemiec Ł; Baumgarten T; Slotboom DJ; de Gier JW; Hjelm A
Microb Cell Fact; 2015 Sep; 14():142. PubMed ID: 26377812
[TBL] [Abstract][Full Text] [Related]
5. Improved conditions for production of recombinant plant sesquiterpene synthases in Escherichia coli.
Picaud S; Olsson ME; Brodelius PE
Protein Expr Purif; 2007 Jan; 51(1):71-9. PubMed ID: 16908191
[TBL] [Abstract][Full Text] [Related]
6. A New Efficient Method for Production of Recombinant Antitumor Cytokine TRAIL and Its Receptor-Selective Variant DR5-B.
Yagolovich AV; Artykov AA; Dolgikh DA; Kirpichnikov MP; Gasparian ME
Biochemistry (Mosc); 2019 Jun; 84(6):627-636. PubMed ID: 31238862
[TBL] [Abstract][Full Text] [Related]
7. High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfide-rich proteins in E. coli.
Nozach H; Fruchart-Gaillard C; Fenaille F; Beau F; Ramos OH; Douzi B; Saez NJ; Moutiez M; Servent D; Gondry M; Thaï R; Cuniasse P; Vincentelli R; Dive V
Microb Cell Fact; 2013 Apr; 12():37. PubMed ID: 23607455
[TBL] [Abstract][Full Text] [Related]
8. Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform.
Hsieh SK; Yu YJ; Tang NY; Lin JR; Jinn TR
Protein Pept Lett; 2017; 24(11):1021-1029. PubMed ID: 28741464
[TBL] [Abstract][Full Text] [Related]
9. Regulating the T7 RNA polymerase expression in E. coli BL21 (DE3) to provide more host options for recombinant protein production.
Du F; Liu YQ; Xu YS; Li ZJ; Wang YZ; Zhang ZX; Sun XM
Microb Cell Fact; 2021 Sep; 20(1):189. PubMed ID: 34565359
[TBL] [Abstract][Full Text] [Related]
10. E. coli HMS174(DE3) is a sustainable alternative to BL21(DE3).
Hausjell J; Weissensteiner J; Molitor C; Halbwirth H; Spadiut O
Microb Cell Fact; 2018 Oct; 17(1):169. PubMed ID: 30376846
[TBL] [Abstract][Full Text] [Related]
11. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.
Joshi BH; Puri RK
Protein Expr Purif; 2005 Feb; 39(2):189-98. PubMed ID: 15642470
[TBL] [Abstract][Full Text] [Related]
12. High Expression Achievement of Active and Robust Anti-β2 microglobulin Nanobodies via
Li D; Ji F; Huang C; Jia L
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394739
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway.
Dvorak P; Chrast L; Nikel PI; Fedr R; Soucek K; Sedlackova M; Chaloupkova R; de Lorenzo V; Prokop Z; Damborsky J
Microb Cell Fact; 2015 Dec; 14():201. PubMed ID: 26691337
[TBL] [Abstract][Full Text] [Related]
14. High-level expression of Bacillus naganoensis pullulanase from recombinant Escherichia coli with auto-induction: effect of lac operator.
Nie Y; Yan W; Xu Y; Chen WB; Mu XQ; Wang X; Xiao R
PLoS One; 2013; 8(10):e78416. PubMed ID: 24194930
[TBL] [Abstract][Full Text] [Related]
15. High-level Expression of Tetanus Toxin Fragment C in Escherichia coli.
Aghaiypour K; Teymourpour R
Arch Razi Inst; 2018 Dec; 73(1):27-38. PubMed ID: 30256036
[TBL] [Abstract][Full Text] [Related]
16. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels.
Miroux B; Walker JE
J Mol Biol; 1996 Jul; 260(3):289-98. PubMed ID: 8757792
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Based Construction of a BL21 (DE3)-Derived Variant Strain Library to Rapidly Improve Recombinant Protein Production.
Li ZJ; Zhang ZX; Xu Y; Shi TQ; Ye C; Sun XM; Huang H
ACS Synth Biol; 2022 Jan; 11(1):343-352. PubMed ID: 34919397
[No Abstract] [Full Text] [Related]
18. Production of soluble regulatory hydrogenase from Ralstonia eutropha in Escherichia coli using a fed-batch-based autoinduction system.
Fan Q; Neubauer P; Gimpel M
Microb Cell Fact; 2021 Oct; 20(1):201. PubMed ID: 34663324
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of DR5 and VEGFR2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesis.
Isakova AA; Artykov AA; Plotnikova EA; Trunova GV; Khokhlova VА; Pankratov AA; Shuvalova ML; Mazur DV; Antipova NV; Shakhparonov MI; Dolgikh DA; Kirpichnikov MP; Gasparian ME; Yagolovich AV
Int J Biol Macromol; 2024 Jan; 255():128096. PubMed ID: 37972835
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production.
Marisch K; Bayer K; Cserjan-Puschmann M; Luchner M; Striedner G
Microb Cell Fact; 2013 Jun; 12():58. PubMed ID: 23758670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
